Back
Results - Announcements
Sales rise 33.32% to Rs 24.73 crore
ANG Lifesciences India reports consolidated net loss of Rs 5.19 crore in the December 2024 quarter
15-Feb-2025, 07:37
Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023.
Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 24.73 | 18.55 | 33 |
| OPM % | -8.69 | -10.30 | - |
| PBDT | -4.42 | -4.45 | 1 |
| PBT | -6.38 | -6.37 | 0 |
| NP | -5.19 | -5.93 | 12 |
Powered by Capital Market - Live News